67 related articles for article (PubMed ID: 9162220)
1. Induction of CD25 expression in human B lymphocytes by pharmacological activators of cellular signalling pathways.
McKay CE; Cushley W
Cytokine; 1996 Apr; 8(4):305-12. PubMed ID: 9162220
[TBL] [Abstract][Full Text] [Related]
2. Soluble CD40 ligand induces expression of CD25 and CD23 in resting human tonsillar B lymphocytes.
Burlinson EL; Graber P; Bonnefoy JY; Ozanne BW; Cushley W
Eur J Immunol; 1996 May; 26(5):1069-73. PubMed ID: 8647169
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-4 signals regulating CD23 gene expression in human B cells: protein kinase C-independent signaling pathways.
Lee CE; Yoon SR; Pyun KH
Cell Immunol; 1993 Jan; 146(1):171-85. PubMed ID: 8425225
[TBL] [Abstract][Full Text] [Related]
4. Recombinant interleukin-4 promotes expression of the CD25 (Tac) antigen at the plasma membrane of high-density human tonsillar B lymphocytes.
Butcher RD; McGarvie GM; Cushley W
Immunology; 1990 Jan; 69(1):57-64. PubMed ID: 2179130
[TBL] [Abstract][Full Text] [Related]
5. IL-4 counteracts anti-mu-induced human B cell proliferation: involvement of a cAMP-dependent inhibitory pathway.
Taieb J; Leca G; Auffredou MT; Galanaud P; Vazquez A
Eur Cytokine Netw; 1991; 2(4):265-72. PubMed ID: 1721849
[TBL] [Abstract][Full Text] [Related]
6. IL-4 promotes anti-Ig-mediated protein kinase C translocation and reverses phorbol ester-mediated protein kinase C down-regulation in murine B cells.
Harnett MM; Holman MJ; Klaus GG
J Immunol; 1991 Dec; 147(11):3831-6. PubMed ID: 1940370
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 4 and soluble CD23 as progression factors for human B lymphocytes: analysis of their interactions with agonists of the phosphoinositide "dual pathway" of signalling.
Gordon J; Cairns JA; Millsum MJ; Gillis S; Guy GR
Eur J Immunol; 1988 Oct; 18(10):1561-5. PubMed ID: 2847932
[TBL] [Abstract][Full Text] [Related]
8. Ligation of CD23 triggers cyclic AMP generation in human B lymphocytes.
Kolb JP; Abadie A; Paul-Eugene N; Capron M; Sarfati M; Dugas B; Delespesse G
J Immunol; 1993 Jun; 150(11):4798-809. PubMed ID: 8388420
[TBL] [Abstract][Full Text] [Related]
9. Activation pathways triggered by interleukin-4 in the human plasmacytoma cell line RPMI-8226--differences with resting B lymphocytes.
Lasfar A; Amirand C; Ballini JP; Kolb JP
Eur Cytokine Netw; 1993; 4(3):213-21. PubMed ID: 8218946
[TBL] [Abstract][Full Text] [Related]
10. Regulation of CD23 expression by IL-4 and corticosteroid in human B lymphocytes. Altered response after EBV infection.
Paterson RL; Or R; Domenico JM; Delespesse G; Gelfand EW
J Immunol; 1994 Mar; 152(5):2139-47. PubMed ID: 8133030
[TBL] [Abstract][Full Text] [Related]
11. Multiple signaling pathways mediate anti-Ig and IL-4-induced early response gene expression in human tonsillar B cells.
Murphy JJ; Norton JD
Eur J Immunol; 1993 Nov; 23(11):2876-81. PubMed ID: 7693480
[TBL] [Abstract][Full Text] [Related]
12. Triggering through CD40 promotes interleukin-4-induced CD23 production and enhanced soluble CD23 release in atopic disease.
Paterson RL; Lack G; Domenico JM; Delespesse G; Leung DY; Finkel TH; Gelfand EW
Eur J Immunol; 1996 Sep; 26(9):1979-84. PubMed ID: 8814234
[TBL] [Abstract][Full Text] [Related]
13. Independent regulation of interleukin 4 (IL-4)-induced expression of human B cell surface CD23 and IgM: functional evidence for two IL-4 receptors.
Rigley KP; Thurstan SM; Callard RE
Int Immunol; 1991 Feb; 3(2):197-203. PubMed ID: 1709049
[TBL] [Abstract][Full Text] [Related]
14. Retinoic acid inhibits CD40 plus IL-4 mediated IgE production through alterations of sCD23, sCD54 and IL-6 production.
Scheffel F; Heine G; Henz BM; Worm M
Inflamm Res; 2005 Mar; 54(3):113-8. PubMed ID: 15883744
[TBL] [Abstract][Full Text] [Related]
15. A combination of IL-10 and direct contact with plasma cell tumors decreases CD23 expression on splenic B cells.
Ruzek MC; Billadeau D; Mathur A
J Immunol; 1996 Mar; 156(6):2124-32. PubMed ID: 8690901
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of CD23 hyperexpression on B cells from patients with rheumatoid arthritis.
De Miguel S; Galocha B; Jover JA; Bañares A; Hernández-García C; García-Asenjo JA; Fernández-Gutiérrez B
J Rheumatol; 2001 Jun; 28(6):1222-8. PubMed ID: 11409113
[TBL] [Abstract][Full Text] [Related]
17. CD23-mediated cell signalling.
Kolb JP; Abadie A; Proschnicka-Chalufour A; de Gramont A; Poggioli J
J Lipid Mediat Cell Signal; 1994 Feb; 9(1):27-35. PubMed ID: 8032713
[TBL] [Abstract][Full Text] [Related]
18. Inhibition by glucocorticoid and staurosporine of IL-4-dependent CD23 production in B lymphocytes is reversed on engaging CD40.
Katira A; Knox KA; Finney M; Michell RH; Wakelam M; Gordon J
Clin Exp Immunol; 1993 May; 92(2):347-52. PubMed ID: 7683590
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-7 modulates CD23 and HLA-DR expression on CD4+ T cells and promotes a Th-2 type citokine profile.
Fratazzi C; Carini C
Allergol Immunopathol (Madr); 1997; 25(4):189-98. PubMed ID: 9269509
[TBL] [Abstract][Full Text] [Related]
20. 1alpha,25-dihydroxyvitamin D3 inhibits anti-CD40 plus IL-4-mediated IgE production in vitro.
Heine G; Anton K; Henz BM; Worm M
Eur J Immunol; 2002 Dec; 32(12):3395-404. PubMed ID: 12432570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
